CSL ( (AU:CSL)) has shared an announcement. CSL Limited has provided an updated notification to the ASX on its ongoing on‑market share buy‑back, confirming that it is purchasing ordinary fully paid ...
ADRs of CSL Limited (OTCQX:CSLLY) dropped ~16% on Tuesday as Wall Street reacted to Australian biotech’s plans to lay off 15% of its workforce, announced in conjunction with its fiscal 2025 financials ...
CSL shares have tumbled again. The post CSL shares: 3 reasons to buy and 3 reasons to sell appeared first on The Motley Fool ...
Fintel reports that on December 8, 2025, JEFFERIES maintained coverage of CSL Limited - Depositary Receipt (OTCPK:CSLLY) with a Buy recommendation. As of December 6, 2025, the average one-year price ...
CSL ( (AU:CSL)) has shared an announcement. CSL Limited has provided an updated notification to the ASX on its ongoing on-market share buy-back program for its ordinary fully paid shares. The update, ...
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with CSL Limited Sponsored ADR (CSLLY) and Techne (TECH). But which of these two stocks offers value investors a ...
Zacks.com on MSN
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either CSL Limited Sponsored ADR (CSLLY) or argenex SE (ARGX). But which of these two stocks is more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results